We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lab21 Secures new Patents in Hepatitis C Drug Resistance and Fluorescent Carbon-Based Nanoparticle Technology

News   Dec 09, 2010

 
Lab21 Secures new Patents in Hepatitis C Drug Resistance and Fluorescent Carbon-Based Nanoparticle Technology
 
 
Advertisement
 

RELATED ARTICLES

How the Hormones You're Born With Influence Disease Risk

News

Differences in biological sex can dictate lifelong disease patterns, says a new study by Michigan State University researchers that links connections between specific hormones present before and after birth with immune response and lifelong immunological disease development.

READ MORE

RNA Nanoparticles’ Rubbery Properties Help Them To Target Tumors

News

A new study shows that RNA nanoparticles have elastic and rubbery properties that help to explain why these particles target tumors so efficiently and why they possess lower toxicity in animal studies.

READ MORE

NIH Facilitates Large-Scale Study of Alzheimer’s Disease Biomarkers

News

To meet the pressing need to better understand the prevalence, progression, and clinical impact of Alzheimer’s disease among Mexican Americans, the National Institutes of Health has added funding for more biomarker measures, including positron emission tomography (PET) imaging, to the ongoing Health and Aging Brain Among Latino Elders (HABLE) Study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE